J. Xiong

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Stefan Zeuzem, Junyuan Xiong, Edward Tam, 2014, The New England journal of medicine.

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Eoin Coakley, Junyuan Xiong, Jordan J Feld, 2014, The New England journal of medicine.

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.

A. Ravaud, L. Dirix, C. Britten, 2018, The Lancet. Oncology.

Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.

A. Ravaud, L. Dirix, C. Britten, 2017 .

Avelumab in patients with metastatic urothelial carcinoma: Pooled results from two cohorts of the phase 1b JAVELIN Solid Tumor trial.

A. Ravaud, L. Dirix, C. Britten, 2017 .

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

O. Weiland, K. Kowdley, D. Nelson, 2014, The New England journal of medicine.

Optimal decision‐making in oncology development programs based on probability of success for phase III utilizing phase II/III data on response and overall survival

Meinhard Kieser, Hakan Demirtas, Heiko Götte, 2020, Pharmaceutical statistics.